Immutep Limited: Surging On Positive Head And Neck Data

Group 1 - Immutep Limited (IMMP, PRRUF) is focused on immunotherapy and is pivoting fully into the development of a LAG3 [1] - The company has received an optimistic investment thesis based on its strategic direction in the biotech sector [1] Group 2 - The author has a PhD in biochemistry and extensive experience analyzing clinical trials and biotech companies, indicating a strong background in the field [1]